MYL6B and rectum adenocarcinoma: In order to determine the role of MYL6B in rectal adenocarcinoma, the overall survival curve was constructed by the Kaplan–Meier method, indicating that upregulation of MYL6B in patients with rectal adenocarcinoma significantly correlated with poor prognosis (Figure 1d, P = 0.022).